Our science and commercialisation leaders have diverse backgrounds but together provide a wealth of expertise for clients and collaborators.
As Institute Director, Richard leads the team, influences its research direction, protects its IP and keeps in touch with collaborators and clients worldwide.
Gary enjoys organic synthesis, medicinal and process chemistry. Creating new enzyme inhibitors, like the potent DADMe-Immucillins, are career highlights.
Peter leads the enzyme inhibitor and heparan sulfate synthesis research programmes and manages the team’s key collaborations.
Phill manages the custom synthesis, scale-up and process development work, linking to GlycoSyn’s cGMP facility. He researches dendrimers for pharmaceutical use.
Gavin leads research in the design and synthesis of drugs, vaccines and immunotherapeutics. One focus is cancer immunotherapy, with the Malaghan Institute.
Simon has a passion to work with industry’s real-world chemical problems using his skill base in natural products, polymer science and cGMP drug manufacture.
Ian has research interests in the structure and function of complex carbohydrates, particularly their effects on gut microbiota and health.